CHICAGO and ALLSCHWIL, Switzerland, Oct. 9, 2006 (PRIMEZONE) -- Actelion Ltd (Other OTC:ALIOF) (SWX:ATLN) announced today that the detailed analysis of the dose-finding study CONSCIOUS-1 (Clazosentan ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results